Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Bliss GVS Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:506197 P/E (TTM) :24.57
ISIN Demat:INE416D01022 Div & Yield %:0.27 EPS (TTM) :7.41
Book Value (RS) :104.3299482 Market Cap (Rs Cr.):1926.42 Face Value (RS) :1
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.070.080.100.110.13
Long Term Debt-Equity Ratio0.040.050.040.040.05
Current Ratio5.655.044.094.074.55
Fixed Assets1.501.511.822.642.25
Inventory7.797.407.297.326.45
Debtors1.611.521.481.681.24
Interest Cover Ratio15.3120.1012.5030.2622.76
PBIDTM (%)19.1523.1823.5522.7223.45
PBITM (%)15.1019.2921.0220.5420.49
PBDTM (%)18.1722.2221.8722.0422.55
CPM (%)14.3916.4616.8216.7417.46
APATM (%)10.3412.5714.2914.5614.50
ROCE (%)9.1611.1812.8114.5911.71
RONW (%)6.747.919.5611.539.38

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)